Bristol-Myers Squibb Company
NYSEBMY cost to borrow surges 112% in one week to 0.71%, signaling tightening lending conditions despite low short interest of 2.1% of float.
Options traders at BMY are flashing their most defensive posture in weeks, just as short sellers quietly cover — and a fresh analyst upgrade adds a layer of conviction to the bull case. The most striking move this week…
Bristol-Myers Squibb enters September with the most interesting tension sitting on the Street rather than in the lending market — a wave of target-price upgrades following Q2 earnings that left the consensus more…
Snapshot as of 20 Sept 2026
Bristol-Myers Squibb has cleared Q2 and the setup has flipped — the shorts that were rebuilding ahead of the July 30 print are now unwinding, while a wave of analyst upgrades and target hikes is pushing the stock to…
Bristol-Myers Squibb reports Q2 earnings on July 30 with the stock at $63.60 and options traders notably relaxed — yet short interest has just posted its sharpest weekly jump in months, creating a quiet tension under…
Bristol-Myers Squibb reports second-quarter results on July 30 with the stock riding its strongest stretch in months, but the debate heading into the print centres on whether a rebuilt pipeline can replace the revenue…
Bristol-Myers Squibb heads into its July 30 earnings print with options positioning unusually skewed toward calls — a notable shift for a stock that has otherwise drifted quietly lower. The clearest signal this week is…
The short build in Bristol-Myers Squibb has continued at pace since Tuesday's note. Short interest now stands at 2.32% of free float — up another 20.8% in a single week and 60% over the past month. Bears that were…
Bristol-Myers Squibb enters the first week of June in an uncomfortable spot: the stock has shed 6.2% over the past week and 6.5% over the past month, while short sellers have been quietly rebuilding positions at the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BMY — free to start on ORTEX.
Sign up for free →Open BMY on ORTEX